Back
Swedbank AB Vs. Axsome Therapeutics Industry Stock Comparison
Sell
44
SWDBY
Swedbank AB
Last Price:
$22.97
Seasonality Move:
-1.89%
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$109.87
Seasonality Move:
19.74%
Sell
44
Swedbank AB (SWDBY)
is a Sell
Is Swedbank AB a Buy, Sell or Hold?
-
The current Swedbank AB [SWDBY] share price is $22.76. The Score for SWDBY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SWDBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SWDBY Stock Price Chart
What is Swedbank AB's stock price today?
-
The Swedbank AB share price today is $22.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWDBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $111.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
SWDBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 33.56 | Sell |
| Chaikin Money Flow: | 12666 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.06 - 26.26) | Sell |
| Bollinger Bands (100): | (19.59 - 24.19) | Buy |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 36.05 | Sell |
| Chaikin Money Flow: | 647254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.19 - 127.47) | Sell |
| Bollinger Bands (100): | (89.52 - 121.2) | Buy |
SWDBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.71 | Sell |
| 20-day SMA: | 25.38 | Sell |
| 50-day SMA: | 23.85 | Sell |
| 200-day SMA: | 21.28 | Buy |
| 8-day EMA: | 24.25 | Sell |
| 20-day EMA: | 24.76 | Sell |
| 50-day EMA: | 23.89 | Sell |
| 200-day EMA: | 21.66 | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 120.51 | Sell |
| 20-day SMA: | 122.32 | Sell |
| 50-day SMA: | 118.5 | Sell |
| 200-day SMA: | 95.68 | Buy |
| 8-day EMA: | 118.83 | Sell |
| 20-day EMA: | 121.23 | Sell |
| 50-day EMA: | 116.96 | Sell |
| 200-day EMA: | 99.27 | Buy |
Swedbank AB Earnings Growth & SWDBY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and an increase next year of $0.07 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Swedbank AB Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||